| abstract |
Drug-resistant tumor cells are rendered drug-sensitive by administering to the tumor cells a pump-affecting compound which suppresses the pumping action of P-glycoprotein on the tumor cells. In the case where the tumor cells have higher β-glucuronidase activity than that of the surrounding tissues, the pump-affecting compound is in the form of a β-D-glucuronide. |